|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 31/517 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Number of the document | 3125935 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15710714.5 |
| Date of filing the European patent application | 2015-03-09 | |
| (97) | Date of publication of the European application | 2017-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/000525 |
| Date | 2015-03-09 |
| (87) | Number | WO 2015/149909 |
| Date | 2015-10-08 |
| (30) | Number | Date | Country code |
| 201461974765 P | 2014-04-03 | US |
| (72) |
HUCK, Bayard R., DE
WILKER, Erik, US
MACHL, Andreas, US
KALETA, Remigiusz, US
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | COMBINATIONS OF CANCER THERAPEUTICS |
| COMBINATIONS OF CANCER THERAPEUTICS |